Sign in
CompletedNo phase

Flu Infection at UPHS

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Status
Completed
People taking part
19 people enrolled
Started
27 Jan 2025
Ended
29 Sept 2026
Type of study
Observational
Treatments tested
  • influenza virus infection
Record updated
7 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Aged 18 years and older
  • Influenza positive test result performed within the University of Pennsylvania Health System

Who cannot take part

  • Immunosuppression as a result of an underlying illness or treatment with immunosuppressive or cytotoxic drugs, or use of anticancer chemotherapy or radiation therapy within the preceding 36 months
  • Treatment with immunoglobulin or another blood product within the 3 months prior to enrollment in this study
  • Any neoplastic disease (excluding non-melanoma skin cancer or prostate cancer that is stable in the absence of therapy) or a history of any hematological malignancy ("active" is defined as having received treatment within the past 5 years)
  • Known latex allergy
  • Known acute or chronic medical condition that, in the opinion of the investigator or appropriate sub-investigator, would interfere with the evaluation of immune responses
  • A known human immunodeficiency virus, hepatitis B, or hepatitis C infection
  • Any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol
  • Pregnancy due to the volume of blood collected in this study
  • Intends to donate blood during the study period
  • Prolonged inpatient hospitalization that disrupts or interferes with study procedures
  • Weigh less than 110lbs

Where in United States

  • Penn Presbyterian Medical CenterPhiladelphia, United States

About the trial

What the trial wants to find out

Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.

Treatments tested

  • influenza virus infection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating Immune Imprinting in the Context of Influenza Virus Infections
Record updated
7 October 2026